Fsrg1 (female sterile homeotic-related gene 1) is the mouse homolog of the human RING3 protein, which has been shown to associate with the E2 promoter binding factor (E2F) transcription factor and to have a possible role in cell cycle-linked transcriptional regulation. The Fsrg1 protein is 60% identical in sequence to the RNA polymerase II mediator subunit Fsrg4, another member of this subfamily of double bromodomain-containing proteins that are homologs of Drosophila female sterile homeotic. Antibodies against murine Fsrg1 were generated and used in immunoblot and immunoprecipitation experiments to identify proteins interacting with Fsrg1 and RING3. In the presence of acetylated but not nonacetylated histone H3 and H4 peptides, RING3 was shown to interact with E2F, mediator components cyclin-dependent kinase 8 and thyroid receptor-associated protein 220, and the RNA polymerase II large subunit. 
Fsrg1 (female sterile homeotic-related gene 1) is the mouse homolog of the human RING3 protein, which has been shown to associate with the E2 promoter binding factor (E2F) transcription factor and to have a possible role in cell cycle-linked transcriptional regulation. The Fsrg1 protein is 60% identical in sequence to the RNA polymerase II mediator subunit Fsrg4, another member of this subfamily of double bromodomain-containing proteins that are homologs of Drosophila female sterile homeotic. Antibodies against murine Fsrg1 were generated and used in immunoblot and immunoprecipitation experiments to identify proteins interacting with Fsrg1 and RING3. In the presence of acetylated but not nonacetylated histone H3 and H4 peptides, RING3 was shown to interact with E2F, mediator components cyclin-dependent kinase 8 and thyroid receptor-associated protein 220, and the RNA polymerase II large subunit. Fsrg1 mRNA had been previously shown to be expressed at high levels in the epithelium of the adult mouse mammary gland. To determine the physiological relevance of these potential associations, we examined the patterns of expression of Fsrg1 mRNA and protein in the adult mammary epithelia during the reproductive cycle as the tissue is responding to estrogen, progesterone, and prolactin. Changes in the nuclear vs. T HE MOUSE GENE Fsrg1 (female sterile homeoticrelated gene 1) 1 was named for its sequence similarity to fsh (female sterile homeotic) of Drosophila (1) . The homology is strongest in two internal regions of the protein coding sequence that correspond to the bromodomain motif and a segment at the carboxyterminal end that is also present in some other bromodomain proteins and has been named the ET (extraterminal) domain. An important role for Fsrg1 in development was suggested by defects caused by mutant fsh alleles in Drosophila (2) . The bromodomain is found in transcription-regulatory proteins in eukaryotes ranging from yeast to humans, including plants. The evolutionary conservation of the Fsrg1/fsh type of gene is shown by the presence of genes coding for proteins with the same arrangement of two bromodomains and an ET domain in yeast [bromodomain factors 1 and 2 (BDF1 and BDF2)] and in man (RING3) (1, (3) (4) (5) (6) . The bromodomains of p300/CREBbinding protein (CBP)-associated factor (7) and TATA binding protein-associated factor II 250 (TAF II 250) (8) have been shown to bind to histone peptides acetylated on lysine side chains, consistent with a role for these proteins in transcription regulation. Deletion of the RING3 ET domain inhibits this protein's association with E2 promoter binding factor (E2F) (9) , and the yeast BDF1 ET domain has been shown to be necessary and sufficient for the interaction of BDF1 with subunits of the basal transcription factor TFIID (transcription factor IID) (4) .
Previous studies examined the developmental regulation of expression of the Fsrg1 mRNA and the intracellular localization of the encoded protein in cultured cells (1) . In addition to expression during embryogenesis, transcription of Fsrg1 was detected in the adult gonads and epithelia of reproductive tissues such as the prostate, epididymis, vas deferens in the male, and mammary gland, oviduct, uterus, and cervix in females (Ref. 1 and Trousdale, R., and D. J. Wolgemuth, in preparation). The nonuniform expression of Fsrg1 mRNA and presence of bromodomains in the encoded protein are consistent with a cell typespecific and possibly gene-specific function in transcription regulation.
Further evidence that Fsrg1 might play a role in developmental regulation of gene expression comes from copurification of one of the related mouse proteins, Fsrg4, with the RNA polymerase II (Pol II) mediator complex (10) . Because mediator is a regulatory complex involved in the recruitment of the holoenzyme to the promoter by a DNA-bound activator, this report suggests that Fsrg1 may also have a role in transcription regulation, possibly making direct contact with the polymerase. Additional biochemical evidence for Fsrg1 function in regulation of Pol II transcription comes from studies of RING3, which is 95% identical in amino acid sequence to Fsrg1 (1). Overexpression of RING3 in cultured cells results in activation of cell cycle-regulatory genes, and this protein is found to copurify with the cell cycle-driving transcription factor E2F (9) .
To gain insight into the function of this bromodomain protein and how its activity is regulated in these processes, we examined 1) the cellular specificity of expression of Fsrg1 mRNA and protein to obtain clues as to possible regulatory targets and physiological relevance, 2) the correlation of nuclear localization of the protein with proliferation and apoptosis in a hormonally modulated tissue system, and 3) the association of the protein with components of the transcriptional machinery and with transcriptionally active chromatin. We chose the pregnancy-induced, secreting mammary epithelia as a system in which to examine these issues. The proliferation and differentiation of mammary epithelium are under the control of steroid hormone receptors and their corresponding coactivators and corepressors, several of which are bromodomain-containing proteins (11, 12) .
RESULTS

Production of New Anti-Fsrg1 Serum and Test of Specificity
The anti-Fsrg1 used for experiments described previously (1) was not effective for immunostaining or immunoprecipitation (IP); therefore, a new antiserum has been generated (see Materials and Methods). The previous antibody consistently detected a strong 110-kDa band in extracts from tissues and cultured cells, and occasionally a weaker band at 150 kDa. The first test of the specificity of the new antibody was to repeat the assay for hemagglutinin-tagged RING3 (RING3-HA) in nuclear extract from transfected HeLa cells. The new antibody detects a single band in anti-Fsrg1 or anti-HA immunoprecipitates that we measure at 120 kDa (Fig. 1A) . The discrepancy between this relative molecular mass and the 110 kDa previously reported (1) is likely due to the different sets of markers being used. The new antibody was then used to assay for the endogenous RING3 in nontransfected HeLa nuclear extract. A band at 120 kDa, comigrating with the RING3-HA band, is seen along with a 150-kDa band, and these two bands are immunoprecipitated by anti-Fsrg1 (Fig. 1B) . Because the RING3-HA expression construct used in the current experiments is the same as that used previously (1) , it provides an internal standard for the migration of the endogenous protein. The 150-kDa protein must include an amino acid sequence not present in the 120-kDa protein, because an anti-HA immunoprecipitate from a nuclear extract from RING3-HA-expressing HeLa cells gives only a 120-kDa band (Fig. 1A) .
Recent results from our laboratory (Shang, E., and D. J. Wolgemuth, in preparation) and another group (5) have revealed genes coding for three proteins similar in sequence to Fsrg1 in mouse, and homologs for each of these three in the human genome. This raises the possibility that the 150-kDa band represents crossreaction of anti-Fsrg1 with one of the other members of this family; in particular, the gene we refer to as Fsrg4 has been found to encode a protein larger than Fsrg1 (5) (this larger protein is designated MCAP in this article), and the portion of this longer sequence that can be aligned with the Fsrg1 sequence is 60% identical. To address this issue, some of the immunoblots shown in Fig. 1 were reprobed with anti-Fsrg4. This antibody detected a 200-kDa band in mouse tissues and HeLa nuclear extract as observed previously (5) but did not detect the 120-kDa or 150-kDa bands seen with anti-Fsrg1 (data not shown). In addition, immunostaining of testis sections with each of these antibodies reveals a nonoverlapping pattern in discrete cell types (Salazar, G., and D. J. Wolgemuth, unpublished observations). The 150-kDa band is definitely not Fsrg4, and because the sequence identity between any pairwise combination of the four mouse Fsrg proteins or the four human homologs is approximately the same, i.e. 60%, it is unlikely that the 150-kDa band is Fsrg2 or Fsrg3.
Association of the Human Homolog of Fsrg1(RING3) with E2F and Components of Mediator Is Stimulated by Acetylated Histones
The binding of bromodomains specifically to histones with acetylated lysine side chains suggests that such contacts might alter the conformation of the bromo-domain-containing protein, thereby affecting its association with other nuclear proteins (7, 8) . To determine whether acetylated histones will affect interaction of Fsrg1/RING3 with other proteins and to determine whether Fsrg1, like Fsrg4, associates with subunits of Pol II mediator, a series of coimmunopreciptation experiments were performed using nuclear extracts from HeLa cells. To increase the efficiency of the precipitations, the cells were transfected with the RING3-HA construct mentioned above, increasing the pool of protein produced by the endogenous RING3 gene. A high-salt extraction procedure that yields extracts containing most of the nuclear proteins but not histones was used (Materials and Methods). To assay for the effects of acetylated histones on interactions between RING3 and other proteins, peptides corresponding to the amino termini of histones H3 and H4, with and without acetylated lysines, were added to the extracts before precipitation.
Previous studies using purification of protein complexes by column chromatography has shown that two of the six isotypes of the E2F protein, E2F-1 and E2F-2, are associated with RING3 in the nuclei of proliferating cells (9) . IP with antibodies specific for E2F-2 brings down both the 120-kDa and 150-kDa RING3 bands in the presence of acetylated histone peptides, but not in the presence of nonacetylated peptides ( Fig. 2A, top panel) . The complex precipitated in the acetylhistone-containing reaction also includes the mediator subunits cyclin-dependent kinase 8 (Cdk8) (13) and thyroid receptor-associated protein 220 (TRAP220) (14) , and the Pol II large subunit (Pol II ls) ( Fig. 2A, lower panels) . As is the case with RING3, the mediator subunits and Pol II do not coimmunoprecipitate in the presence of nonacetylated histone peptides. These data support the observations of E2F-2-RING3 association by other investigators (9) and provide evidence that RING3 and Fsrg1 contact subunits of the Pol II mediator complex. A complementary assay for these protein-protein interactions was performed by immunoprecipitating RING3 from the nuclear extracts with anti-Fsrg1 serum, and then assaying for coprecipitation of the other proteins by immunoblot. E2F-2 is coprecipitated with RING3 specifically in the presence of the acetylated peptides. The same is true for Cdk8, TRAP220, and Pol II large subunit (Fig. 2B ). RING3 protein produced by the endogenous gene as well as the RING3-HA from the A, Immunoblot, probed with anti-HA, of immunoprecipitates from 300-g aliquots of nuclear extract from RING3-HA-transfected HeLa cells. The anti-Fsrg1 is a rabbit serum; therefore, protein A-Sepharose is used to pull down antibody-antigen complexes, and the two negative control lanes are precipitations with two batches of rabbit preimmune sera plus protein A. The anti-HA is a mouse monoclonal; therefore, protein G-Sepharose is used to pull down complexes, and the negative control lane is precipitation with rabbit preimmune plus protein G. RING-HA is precipitated by either of the two antisera and runs at 120 kDa. Only very weak signals are seen at this molecular mass in the control lanes. The weak band at 73 kDa in the first three lanes is probably due to nonspecific binding of protein A with a protein unrelated to Fsrg1/RING3, because it is equally strong in the negative control lanes. B, Immunoblot, probed with anti-Fsrg1, of whole nuclear extract from HeLa cells (70 g), and IPs from 300-g aliquots of HeLa nuclear extract. The anti-Pol II (large subunit) and anti-TRAP220 (mediator subunit) precipitations serve as negative controls to show the specificity of the anti-Fsrg1 precipitation. Only a very weak 150-kDa band is detected in these control lanes.
transfection construct is being assayed in these co-IP experiments because the anti-Fsrg1 can pull down both proteins (direct IP, shown in Fig. 1 ). Detection of the 150-kDa band in the co-IPs verifies that protein from the endogenous gene is being assayed because this band is not produced by the RING3-HA construct (Fig. 1A ).
Fsrg1 mRNA Is Expressed in Mammary Epithelia During Pregnancy, Lactation, and Involution, and Nuclear Import of the Protein Is Regulated
Fsrg1 had previously been reported to be expressed at high levels in the adult mouse mammary epithelium (1). The mammary epithelium undergoes dramatic morphological and physiological changes during pregnancy, lactation, and the postlactation involution process, providing a good system in which to examine expression and intracellular localization of a putative transcription regulator such as the Fsrg1 protein in vivo. A histological section of mammary gland from a virgin mouse shows predominantly fat cells with sparsely distributed, tubular milk duct epithelia. These ducts carry the milk to the nipple during lactation; however, it is the alveoli, a distinct type of epithelia that bud from the walls of the duct epithelia during pregnancy, that secrete the milk. By the end of the 18-d pregnancy period, the alveoli dominate the gland, having replaced most of the fat cells. A section of a gland Immunoprecipitates from aliquots of RING3-HA-transfected HeLa nuclear extract (300 g), preincubated with nonacetylated peptides (H3 and H4) or acetylated peptides (acH3 and acH4), were assayed for co-IP by immunoblot. Positive control lanes contained 70 g of unprecipitated nuclear extract. A, IP with anti-E2F-2, assay for co-IP with anti-Fsrg1, anti-Cdk8, anti-TRAP220, and anti-Pol II ls. The bands detected migrate at 120 kDa and 150 kDa (RING3), 60 kDa (Cdk8), 217 kDa (TRAP220), and 217 kDa (Pol II ls). B, IP with anti-Fsrg1, assay for co-IP with anti-E2F-2, anti-Cdk8, anti-TRAP220, and anti-Pol II ls. E2F-2 migrates at 65 kDa. The bottom panel in each column shows a probe for the protein directly contacted by the antibody used for IP (E2F-2 in column A and RING3 in column B), to verify that efficiency of the direct IP is the same regardless of which histone peptide is present. The band above E2F-2 in the bottom panel in column A (IgG hc) is due to cross-reaction of the secondary antibody used for detection on the immunoblot with the IgG heavy chain of the antibody used for IP.
at this point in the reproductive cycle shows the alveoli as a network of adjacent epithelial rings, and because the cell volume is greater than that of the duct epithelial cells, the nuclei in the alveoli are spaced farther apart than those in the ducts. This characteristic is particularly advantageous for examining nuclear vs. cytoplasmic localization of proteins. During the 21-d lactation period, most of the alveolar cells exit the cell cycle (15, 16) , and the morphology of this tissue remains static while milk is being secreted. Between 2 and 5 d after the end of lactation, the basal lamina that has been maintaining the shape of the alveolar epithelium is broken down by secreted proteinases, resulting in the involution of these structures, concominant with the entry of the alveolar cells into programmed cell death (apoptosis). Fat cells reappear to fill the void left by the loss of alveoli, and the gland eventually returns to the virgin morphology. Hormones play a key role in these changes in the alveoli, with the pregnancyspecific prolactin and progesterone, in addition to estrogen, stimulating the proliferation, whereas a rapid drop in progesterone and estrogen at parturition allows prolactin to induce lactation. Secretion of the extracellular matrix protein tenascin is one of the signals that triggers involution and apoptosis (16) (17) (18) (19) .
To determine whether Fsrg1 is also expressed in the alveoli and whether it is variable in different physiological contexts, in situ hybridization on tissue samples from pregnant, lactating, and postlactation animals was performed. Fsrg1 mRNA was detected in the budding alveoli during pregnancy (Fig. 3A) and continued to be present as these epithelial rings expand to their maximum size during lactation (Fig. 3B ) and during postlactation involution (Fig. 3, C and D) . The signal is strongest in the budding alveoli.
To determine whether the Fsrg1 message is translated in the alveolar cells during the reproductive cycle and to assay for regulation of intracellular localization of Fsrg1 protein, immunofluorescent staining was performed on tissue sections similar to those described above for the in situ hybridizations. As the alveoli are budding during pregnancy, a punctate nuclear signal is seen for Fsrg1 (Fig. 4A) . When the alveoli become fully expanded into rings and lactation begins, Fsrg1 continues to be expressed in all the cells; however, it is sequestered in the cytoplasm (Fig. 4E) . Two days after lactation has ceased, Fsrg1 returns to the nucleus in the alveolar cells (Fig. 4I) and remains there as involution proceeds (Fig. 4M) .
To verify that the nuclear staining pattern observed for Fsrg1 in alveolar cells is, in fact, chromatin localization, and to determine the specificity of Fsrg1 nuclear import, alveoli at the various stages of the reproductive cycle were stained for the chromatin remodeling enzymes CREB-binding protein (CBP) (20) and histone deacetylase 1 (HDAC1) (21) . Because CBP has histone acetyltransferase activity, CBP and HDAC1 have opposing functions, but transcription regulation of eukaryotic genomes involves a balance of these activities. Activation of a promoter requires acetylation of a subset of the lysines on the histones, whereas repression is affected by deacetylation of the majority of the histone lysines. Thus, both CBP and HDAC1 are expected to be present on chromatin in cells that are transcribing some genes while keeping others repressed (22) . Like Fsrg1, CBP and HDAC1 are localized to the nucleus in a punctate pattern in all cells of the budding alveoli during pregnancy (Fig. 4 , B and C); however, in the expanded rings during lactation, 80-90% of the cells no longer express either protein. In those cells that continue to express these proteins, the punctate nuclear pattern is still observed (Fig. 4, F and G) . None of the alveolar cells show cytoplasmic sequestration of the chromatin remodeling enzymes as is observed for Fsrg1 during lactation; however, both CBP and HDAC1 reappear in all alveolar nuclei at the same timepoint as Fsrg1, i.e. 2 d post lactation (Fig. 4 , J and K). Nuclear localization of CBP and HDAC1 continues as involution proceeds (Fig. 4,  N and O) .
The presence of Fsrg1 in the nucleus of alveolar cells appears to be correlated with cell proliferation and the initiation of apoptosis. This correlation is strengthened by the observation that Ki-67, a nuclear protein expressed specifically in proliferating cells [during all phases of the cell cycle (23)], is detected in the nuclei of budding alveoli but not in the expanded alveolar rings during lactation (Fig. 4, D and H) . Except for the fact that Ki-67 is not sequestered in the cytoplasm during lactation, this expression pattern corresponds to that observed for Fsrg1. The significance of both Fsrg1 (Fig. 4I) and Ki-67 (Fig. 4L ) reappearing in the alveolar nuclei at 2 d post lactation as the cells are preparing for apoptosis is addressed in Discussion.
Fsrg1 Protein Localizes to the Euchromatin in the Mammary Gland Epithelial Cells
The DNA in the heterochromatin near the centromeres consists of predominantly A-T base pairs and is never transcribed, whereas the remainder of each chromosome, the euchromatin, contains the genes and averages 40% G-C base pairs (22) . The DNA stain DAPI (4Ј6-diamidino-2-phenylindole) binds specifically to A-T base pairs, producing a much stronger signal on the heterochromatin than on the euchromatin (24) . Immunostaining for a protein involved in Pol II transcription regulation is therefore expected to give a chromatin staining pattern that does not overlap the strongest DAPI signal. Consistent with the hypothesis that Fsrg1 has a role in transcription regulation, the nuclear antibody signal is restricted to the euchromatin; i.e. it does not overlap the DAPI signal (Fig. 4, A, I , and M).
To further assay whether the Fsrg1 nuclear distribution pattern in mammary epithelia is consistent with a role in transcription, Fsrg1 and Cdk8 were localized simultaneously. Cdk8 is the heterodimeric partner of cyclin C and a well characterized mediator subunit (13) . A double immunofluorescence stain of alveoli from 2-d postlactation tissue shows a punctate nuclear pattern for Cdk8 (Fig. 5B) , similar to that observed for Fsrg1 (Fig. 5C) , and a merge of the two signals demonstrates coincident localization of these proteins (Fig. 5D) . When any of the four proteins assayed in mammary epithelia is found in the nucleus, a punctate pattern, not overlapping the DAPI pattern, is seen. These proteins are associated with euchromatin in mammary epithelia as expected.
DISCUSSION
The presence of bromodomains in the Fsrg1 protein, its sequence similarity to a mediator subunit (Fsrg4), and the expression of Fsrg1 mRNA in reproductive epithelia known to respond to hormones provided several clues as to the function and regulation of this protein. These clues prompted experiments that have demonstrated association of Fsrg1/RING3 with E2F-2, mediator subunits, and Pol II in an acetylhistonedependent manner. The association of Fsrg1 protein with E2F-2, the high level of Fsrg1 mRNA in the budding mammary alveoli during pregnancy, and the exclusion of the protein from the nucleus in the G 0 alveolar cells during lactation are all consistent with a role for Fsrg1 in cell cycle progression. The return of Fsrg1 to the nucleus of mammary alveolar cells just before involution and apoptosis hints at a role in initiation of the programmed cell death pathway. In the cells that import Fsrg1 into the nucleus, this protein is localized to the transcribed portion of the chromatin, consistent with the role in transcription regulation predicted by the protein-protein interactions mentioned above.
The immunoblot results with the new anti-Fsrg1 antibody are consistent with results obtained with the previous antiserum (1), indicating specificity of antibody for Fsrg1, although the 150-kDa band is more prominent in the current experiments. A longer coding sequence, not represented in the cDNAs analyzed to date, may be present in RING3 and produce the 150-kDa band. Alternatively, this band might be due to formation of a covalent heterodimer of some of the RING3 molecules (that migrate at 120 kDa) with a 30-kDa protein. The 150-kDa band may be more prominent on the current immunoblots because proteinase activity was suppressed more efficiently by inhibitors in the extraction buffers.
The mediator complex is closely associated with Pol II and has a role in recruitment of the holoenzyme to promoters by activators. Mediator has been observed in yeast, Caenorhabditis elegans, Drosophila, and mouse, and mutations in some of the metazoanspecific subunits cause nonlethal phenotypes, implying cell type-specific functions (13, 14, (25) (26) (27) . Our observations that the human RING3 appears to associate with the Cdk8 and TRAP220 mediator subunits, and the Pol II large subunit, in the nuclei of HeLa cells suggests that like Fsrg4, the mouse Fsrg1 functions by contacting mediator.
Evidence of a role for the Fsrg1 protein in cell cycleregulated Pol II transcription comes from biochemical and cell culture expression studies of RING3. Overexpression of RING3 in transfected BALB/3T3 (mouse) cells results in activation of transcription of several cell cycle-regulatory genes, and column chromatography purification produces a 330-kDa complex containing RING3 and the cell cycle regulation transcription factor E2F-2 (9). E2F-2 is a sequence-specific DNA-binding activator. We have used the co-IP technique to verify the association between RING3 and E2F-2 reported by Denis and colleagues (9) , and the presence of mediator subunits in the complexes immunoprecipitated by antibodies to either of these proteins provides insight into the mechanism by which RING3, and presumably Fsrg1, assists E2F-2 in activating transcription. The euchromatic localization of Fsrg1 that we have observed in the interphase nuclei of mammary epithelial cells is consistent with the hypothesized role of this protein in transcription regulation. The restricted expression of Fsrg1 mRNA and protein suggests cell type-specific and probably gene-specific functions, as has been reported for the various metazoan mediator subunits (13, 14, (25) (26) (27) .
Bromodomains have been observed in components of the various complexes recruited to Pol II promoters as part of the process of transcription activation or repression, such as chromatin-remodeling enzymes, coactivators and corepressors, the basal transcription factor TFIID, which includes the TATA-binding protein, and the polymerase holoenzyme which includes the mediator complex (28) . Of particular relevance to our studies on reproductive tissues is the presence of bromodomains in coactivators known to associate with steroid hormone receptors. The human homologs of the Drosophila brahma, hBRM and BRG1, associate with the glucocorticoid receptor (12, 29) , and human hSNF2 functions with the estrogen and retinoic acid receptors (11) . The finding that some histone acetyltransferases contain bromodomains gave rise to speculation that this motif might have the ability to bind acetylated histones. Because the addition of acetyl groups to lysine residues near the amino terminus of histones on Pol II promoters precedes recruitment of the multiprotein complexes mentioned above, it was suggested that the bromodomain might allow for tethering of histone acetyltransferases and the other complexes to the remodeled promoter. Support for this idea has been provided by the specific binding of peptides including the single bromodomain of the chromatin-remodeling enzyme p300/CBP-associated factor (7), and the double bromodomain of TAF II 250 (8) , to only the acetylated form of peptides corresponding to the amino termini of histones H3 and H4.
At least 43 bromodomain proteins have been identified, and most of these have only one copy of this 110-amino acid motif; however 16 of these, including the four mouse Fsrgs and their human homologs, have two copies (6) . This defines a subclass of bromodomain proteins and suggests that the function of Fsrg1 may be more similar to that of the other Fsrgs than to other bromodomain proteins. Our observations that association of RING3 with E2F, mediator subunits, and Pol II is dependent on the presence of acetylated histone peptides suggests that in addition to tethering protein complexes to a remodeled promoter, the bromodomain-histone contact might have an allosteric effect that alters the conformation of the bromodomain protein in a way that strengthens interactions with other transcription-regulatory proteins. It is possible such an allosteric effect could involve the ET domain because it is known to be necessary for association of RING3 with E2F (9), and necessary and sufficient for association of yeast BDF1 with the TAFs of TFIID (4) .
Regulation of nuclear import is known to control the activity of a number of sequence-specific DNA-binding proteins including NF-B, some steroid hormone receptors (30, 31) , and the Drosophila heat-shock transcription factor HSF (32); however, we are not aware of any previous examples of such regulation for a putative coactivator/corepressor such as Fsrg1. The Fsrg1 protein is nuclear in the dividing cells of the budding alveoli during pregnancy but becomes restricted to the cytoplasm once the alveoli have become fully expanded, are secreting milk, and have exited the cell cycle. The active cell cycle in the budding alveoli is confirmed by the presence of Ki-67 in the nucleus, whereas the G 0 status of alveolar cells during lactation is verified by the absence of this protein. It is possible that the redistribution of Fsrg1 is caused by the variation in hormone levels mentioned earlier. The absence of Fsrg1 signal in the alveolar nuclei during lactation is not due to lack of penetration of the antibody, because both CBP and HDAC1 were detected in some of these nuclei. Lack of expression of CBP and HDAC1 in 80-90% of the cells during lactation is probably related to the exit from the cell cycle. Expression of HDAC1 in mouse T-cells in culture is dramatically reduced when these cells exit the cycle (21) . The colocalization of Fsrg1 and the mediator subunit Cdk8 on euchromatin in 2-d postlactation alveoli, detected in the double immunostain experiment, is consistent with a transcription function for Fsrg1. The only inconsistency in a proposed transcriptional role for Fsrg1 is that 10-20% of the alveolar cells have CBP and HDAC1 in their nucleus during lactation, but none show Fsrg1 in the nucleus.
The return of Fsrg1 and CBP to the nucleus in alveolar cells 2 d after the end of the lactation period may be related to the need for activation of genes involved in breaking down the basal lamina during involution and in the initiation of apoptosis. This theory is consistent with the increase in Fsrg1 mRNA abundance observed in the superior cervical ganglia just before these cells enter apoptosis in the 3-d postnatal rat (33) . The apparent contradiction in the expression of a potential transcription regulator being linked to both cell proliferation and programmed cell death can be addressed as follows. There are several examples of genes that were first characterized as inducers of cell proliferation that have subsequently been found to be up-regulated as the program of apoptosis in initiated. One example is cyclin D1 in neuronal programmed cell death (33) and in mammary epithelial cells (34) . The oncogne c-myc is also up-regulated in the alveoli specifically during the pregnancy growth phase and in the 2 d after the end of lactation when these cells are preparing for programmed death (18) . The reappearance of the cell proliferation marker Ki-67 in the alveolar nuclei as they prepare for apoptosis may be another example of this dual role. The simultaneous presence of conflicting signals, some that promote the cell cycle and others that inhibit it, may trigger programmed cell death (33) . It is possible that Fsrg1 has a role in both proliferation and induction of apoptosis in mammary epithelia, and that different levels of expression or variation in expression of other regulatory factors gives rise to these distinct phenomena. Support for our observations of regulated nuclear import of Fsrg1 is provided by report of similar regulation for the human homolog, RING3, in cultured cells. In this case, translocation to the nucleus occurs if the cells are dividing rapidly and serum is in the culture medium, but not in starved cells (35) . Although this is not a developmental system, the correlation between nuclear localization and cell proliferation is consistent with our Fsrg1 results.
MATERIALS AND METHODS
Source of Cell Lines and Tissues
HeLa is a human cervical carcinoma cell line. The synthesis of the RING3-HA expression construct and introduction into HeLa cells was done previously in this laboratory (1) . Mice were of the CD1 strain (Charles River Laboratories, Inc., Wilmington, MA) and were 2 months old at the beginning of pregnancy.
Antisera
Bacterial expression of recombinant Fsrg1 protein (residues 51-651), antigen purification, and affinity-purification of the rabbit anti-Fsrg1 serum were performed as previously de-scribed (1). The serum was produced at Covance Laboratories, Inc. (Denver, PA). Rabbit antibodies against CBP and HDAC1, and the acetylated histone peptides (acH3: residues 7-18, lysine 14 acetylated; acH4: residues 2-20, lysine 8 acetylated) were purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Rabbit antibodies against Cdk8, TRAP220, and Pol II large subunit, the anti-E2F-2 monoclonal, and the nonacetylated histone peptides (H3: residues 1-20; H4: residues 1-18) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Rabbit anti-Ki67 was from Novocastra (Burlingame, CA), and the monoclonal 12CA5 (anti-HA) was a gift of J. Kitajewski.
Nuclear Extracts and IP
Nuclear extracts were prepared from rapidly dividing untransfected HeLa cells or HeLa cells transfected with a construct containing the HA-tagged RING3 coding sequence downstream of the cytomegalovirus promoter (35) . To boost RING3-HA expression, trichostatin A, a histone deacetylase inhibitor known to stimulate transcription from the cytomegalovirus promoter, was added to a concentration of 3 M when the culture reached 80% confluency (24 h before harvesting). A 3-liter batch of cells, grown to a density of 5 ϫ 10 8 cells/liter, was harvested in PBS, and cells were spun down and then resuspended in hypotonic buffer [10 mM HEPES, pH 7.9; 1.5 mM MgCl 2 ; 10 mM KCl; and 0.5 mM dithiothreitol (DTT)]. Cells were spun down again and resuspended in 5 volumes of fresh hypotonic buffer. The cells were incubated on ice for 10 min and then spun down at 2000 rpm in a Sorvall SS34 rotor. The cell pellet was resuspended in one volume of hypotonic buffer, transferred to a Dounce homogenizer, and homogenized until more than 90% of the cells were disrupted and nuclei released. The nuclei were then pelleted in a Sorvall SS34 at 6000 rpm for 20 min, resuspended in 5 ml of hypertonic buffer (20 mM HEPES, pH 7.9; 25% glycerol; 420 mM NaCl; 1.5 mM MgCl 2 ; 0.2 mM EDTA; 0.5 mM DTT; and proteinase inhibitors: 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 1 g/ml leupeptin, and 1 g/ml pepstatin A), and incubated at 4 C on a rocker for 45 min to allow the high salt to extract proteins from the nuclei. The preparation was then dialyzed overnight against 20 mM HEPES, pH 7.9; 20% glycerol; 100 mM KCl; 0.2 mM EDTA; 0.5 mM DTT to reduce the salt concentration, and the nuclear membranes were then spun down for 5 min at 13,000 rpm in a minifuge. The supernatant, which contained 9 mg/ml of extracted nuclear proteins, was then used for IP.
For single IP reactions, 300 g aliquots of nuclear extract were mixed with 5 l of unpurified anti-Fsrg1 serum or mouse monoclonal 12CA5 (anti-HA), or 2 g of anti-TRAP220 or anti-Pol II ls (both rabbit sera), and the sample was incubated at 4 C overnight. Immune complexes were then precipitated by addition of 400 g of protein A-Sepharose to the reactions with rabbit antibody, or protein G-Sepharose to the reactions with mouse antibody, and incubation at 4 C with agitation for 6 h. Complexes were then spun down, washed in Trisbuffered saline, resuspended in sodium dodecyl sulfate gel loading buffer and boiled for 60 sec before electrophoresis.
For the co-IP reactions, trichostatin A was added to 300 nM followed by the histone peptides at 35 M, and the mixture was incubated on ice for 60 min to allow nuclear proteins to bind the peptides (trichostatin was added first to prevent deacetylation of the peptides). Antibodies were then added as follows: 5 l per reaction of unpurified anti-Fsrg1 serum or 2 g of anti-E2F-2 (a mouse monoclonal), and the preparation was incubated at 4 C overnight. Immune complexes were then precipitated and prepared for electrophoresis as for the single IP reactions.
Immunostaining
Tissue sections were prepared and stained with primary antibodies as previously described (36) . An Alexa Fluor 594-conjugated goat-antirabbit (Molecular Probes, Inc., Eugene, OR; excitation/emission 590/617 nm, red fluorescence), or a fluorescein isothiocyanate (FITC)-conjugated swine-antigoat (Roche Molecular Biochemicals, Indianapolis, IN), secondary antibody was used. The counterstain was DAPI. Images were produced with an LSM 510 NLO Multiphoton confocal microscope (Carl Zeiss, Thornwood, NY). A helium-neon laser (543 nm) produced the red Alexa Fluor signal, an argon laser (480 nm) produced the green FITC signal, and a titanium 2-photon laser (850 nm) produced the blue DAPI signal (converted to green in some of the images). An eight-section Z-series, at 0.8-m intervals, was captured with each laser, the signals were merged, and a projection was made of each series.
In Situ Hybridization
Antisense RNA, labeled with 35 S-UTP and synthesized with T7 polymerase from a cDNA fragment corresponding to the coding sequence between the two bromodomains of the Fsrg1 protein (nucleotides 1698-2340 of the sequence previously described in Ref. 1) , was used to probe for the Fsrg1 transcript. Sense strand RNA, synthesized from the same template with T3 polymerase, was used as the negative control. Sections from paraffin-embedded tissue (5 m thick) were hybridized with the probes and a signal was produced as previously described (37) . The preparations were counterstained with hematoxylin and eosin, and then photographed using a combination of brightfield illumination and fluorescence, with an immunogold stain (green) filter.
